Proficio Capital Partners LLC Sarepta Therapeutics, Inc. Transaction History

Proficio Capital Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$104.54 - $137.94 $3.29 Million - $4.34 Million	31,492 New	31,492 $3.83 Million
Q1 2023 Apr 19, 2023	BUY	$117.53 - $155.99 $2.01 Million - $2.67 Million	17,091 New	17,091 $2.36 Million
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $3,567 - $7,688	-49 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $2,805 - $3,798	25 Added 104.17%	49 $7,000
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $2,560 - $3,640	24 New	24 $3,000

534

85.3M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.68B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.